Edit

Blue Wire Capital

https://www.bluewirecapital.com
Last activity: 08.05.2025
Active
Portfolio
1
Mentions
8
Investment Type: Venture Capital

Portfolio 1

DateNameWebsiteTotal RaisedLocation
20.03.2023Patchpatch.work$4.77M-

Mentions in press and media 8

DateTitleDescription
13.05.2025The Rise of Lab-Grown Innovations: A New Era in Sustainable ProductionIn the world of biotechnology, two companies are making waves. Faircraft and Vivici are not just players; they are pioneers. Their recent moves signal a shift toward sustainable production. This is a game-changer for industries reliant on t...
08.05.2025France’s Faircraft Secures VitroLabs’ Patent Portfolio Through US Asset AcquisitionFrench biotechnology company Faircraft has acquired key assets from VitroLabs, a California-based firm specializing in the development of lab-grown leather. The acquisition includes a portfolio of 30 patents and expands Faircraft’s intellec...
06.05.2025Faircraft acquires VitroLabs assets in effort to dominate lab-grown leather marketFrench biotech Faircraft has announced acquired key assets from VitroLabs, a California-based startup also working to create lab-grown leather. The move is designed to fast-track the industrialisation of in vitro leather production, as the ...
28.02.2025Reviving the Unrevivable: Ignota Labs’ Bold Leap into Drug DevelopmentIn the world of pharmaceuticals, failure is a common companion. Over half of all clinical trials stumble and fall, leaving behind a trail of lost hope and wasted resources. This staggering reality costs the industry an estimated $400 billio...
26.02.2025Ignota Labs raises $6.9M to rescue failing drugs with AI technologyUK pharmatech company Ignota Labs has raised $6.9 million Seed funding to advance its efforts in rescuing promising but failing drugs. Drug safety failures are a leading cause of clinical trial failures, preventing over 56 per cent of drugs...
26.02.2025Rescuing drugs: Ignota Labs raises €6.6 million to turn around failed drugsLondon-based Ignota Labs, an AI-driven drug turnaround company, today announced the close of a €6.6 million Seed funding round, to advance into early-stage clinical trials of their first asset, a PDE9A inhibitor. The round was co-led by Mon...
20.12.2024USD2.5 million to modernize media monetization Online media has become fragmented, the user-onboarding process is tiresome and time-consuming. This is negatively impacting both user engagement levels and media income. The tiun team believes that consuming and paying for online content ...
26.08.2022Reducing battery manufacturing costs of EVs, Bristol-based graphene startup Anaphite drives in £4.1 millionEncouraged by the upcoming ban in 2035 on all new sales of petrol and diesel cars in the U.K., Europe and the U.S., there has been an accelerated demand for reliable and inexpensive EVs. It is estimated that over 50% of all cars in the U.K....

Reviews 0

Sign up to leave a review

Sign up Log In